Trial Profile
A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Metronidazole (Primary)
- Indications Bacterial infections; Bacterial vaginosis
- Focus Registrational; Therapeutic Use
- Sponsors Medicis Pharmaceutical Corporation
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2012 Planned End Date changed from 1 May 2013 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 09 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.